Provided by Tiger Fintech (Singapore) Pte. Ltd.

Humacyte, Inc.

1.48
-0.0200-1.33%
Post-market: 1.510.0299+2.02%17:32 EDT
Volume:2.03M
Turnover:3.00M
Market Cap:234.39M
PE:-3.36
High:1.53
Open:1.51
Low:1.45
Close:1.50
52wk High:6.77
52wk Low:1.15
Shares:158.37M
Float Shares:125.19M
Volume Ratio:0.77
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4403
EPS(LYR):-1.2551
ROE:-249.75%
ROA:-50.18%
PB:57.85
PE(LYR):-1.18

Loading ...

Humacyte Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 31

BTIG Adjusts Price Target on Humacyte to $8 From $10, Maintains Buy Rating

MT Newswires Live
·
Mar 28

Humacyte Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 28

Humacyte Q4 2024 GAAP EPS $(0.16) Beats $(0.25) Estimate, Cash Balance Of $95.3M

Benzinga
·
Mar 28

BRIEF-Humacyte Q4 Operating Income USD -28.088 Million Vs. IBES Estimate USD -29.9 Million

Reuters
·
Mar 28

Press Release: Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

Dow Jones
·
Mar 28

BUZZ-U.S. STOCKS ON THE MOVE-SurgePays, B. Riley, CarMax

Reuters
·
Mar 27

Humacyte Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 26

BRIEF-Humacyte To Present Fourth Quarter And Full Year Financial Results And Provide Corporate Update On March 28, 2025

Reuters
·
Mar 26

BUZZ-U.S. STOCKS ON THE MOVE-Dollar Tree, GameStop, Humacyte

Reuters
·
Mar 26

BUZZ-Humacyte tumbles on pricing $50 mln stock offering

Reuters
·
Mar 26

US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert

Benzinga
·
Mar 26

Humacyte Prices $50 Million Stock Offering

MT Newswires Live
·
Mar 26

BRIEF-Humacyte Prices Public Offering Of 25 Million Shares At $2.00 Per Share

Reuters
·
Mar 26

Humacyte's Stock Drops Below 52-Week Low Amidst Share Sale

Dow Jones
·
Mar 26

BUZZ-Humacyte tumbles on planned equity raise

Reuters
·
Mar 26

Humacyte Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
Mar 21